Skip to main content
Premium Trial:

Request an Annual Quote

Neurocrine Licenses Genedata s Expressionist for Biomarker Discovery

NEW YORK, Dec. 7, (GenomeWeb News) - Biopharmaceutical company Neurocrine Biosciences has licensed Genedata's Expressionist for biomarker discovery and in silico prediction, Genedata said today.


Neurocrine will use Expressionist in a pre-clinical discovery program focusing on neurological and endocrine related diseases and disorders, Genedata said.


Scientists at Neurocrine have already used Expressionist to process and evaluate over 1,500 microarrays, said Bill Wilson, Neurocrine's head of information technology, in a statement.


Financial details were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more